Results
625
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
625 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
9992 | HK$108.10 | -2.4% | 437.8% | HK$143.4b | HK$101.68 | PE87.7x | E36.8% | 0.3% | Retail | ||
600760 | CN¥45.90 | -0.9% | 19.6% | CN¥126.5b | CN¥53.90 | PE51.4x | E29.4% | 0.6% | Capital Goods | ||
RHM | €894.20 | 9.4% | 117.9% | €38.8b | €862.93 | PE56.7x | E30.5% | 0.6% | Capital Goods | ||
6181 | HK$548.50 | 11.3% | n/a | HK$92.3b | HK$482.70 | PE106.8x | E41.3% | n/a | Consumer Durables | ||
ONON | US$48.44 | -6.9% | 50.4% | US$15.5b | US$63.62 | PE110.4x | E30.2% | n/a | Consumer Durables | ||
ALNY | US$250.59 | -2.3% | 59.0% | US$32.4b | US$301.27 | PS14.4x | E59.1% | n/a | Pharmaceuticals & Biotech | ||
ARES | US$174.09 | -6.5% | 32.0% | US$55.1b | US$198.57 | PE79.7x | E41.4% | 2.6% | Diversified Financials | ||
NVDA | US$134.43 | -3.2% | 70.6% | US$3.3t | US$172.22 | PE52.2x | E21.6% | 0.03% | Semiconductors | ||
300308 | CN¥118.73 | 10.5% | 12.5% | CN¥131.2b | CN¥192.85 | PE28.3x | E33.3% | 0.3% | Tech | ||
NU | US$10.82 | -21.0% | 5.9% | US$51.8b | US$14.99 | PB6.8x | E27.6% | n/a | Banks | ||
2382 | NT$270.00 | 3.8% | 12.0% | NT$1.0t | NT$358.05 | PE19.2x | E20.8% | 3.3% | Tech | ||
300502 | CN¥121.04 | 11.0% | 101.9% | CN¥85.8b | CN¥161.36 | PE45x | E36.6% | 0.1% | Tech | ||
2345 | NT$721.00 | -0.6% | 35.5% | NT$403.0b | NT$870.00 | PE41.4x | E33.7% | 1.4% | Tech | ||
A012450 | ₩660,000.00 | 23.8% | 285.6% | ₩30.0t | ₩614,150.00 | PE44.4x | E30.0% | 0.3% | Capital Goods | ||
A196170 | ₩392,000.00 | -0.5% | 198.8% | ₩20.9t | ₩565,000.00 | PS280.9x | E140.6% | n/a | Pharmaceuticals & Biotech | ||
ALAB | US$85.72 | -2.4% | n/a | US$13.9b | US$124.53 | PS35.1x | E61.1% | n/a | Semiconductors | ||
600989 | CN¥15.70 | -5.5% | 6.1% | CN¥115.1b | CN¥21.74 | PE18.3x | E38.5% | 1.8% | Materials | ||
ITCI | US$128.60 | 0.6% | 83.3% | US$13.7b | US$132.73 | PS20.1x | E50.0% | n/a | Pharmaceuticals & Biotech | ||
KSPI | US$102.15 | -6.4% | -1.3% | US$19.4b | US$132.85 | PE10.1x | E20.8% | 6.6% | Diversified Financials | ||
BAM | CA$83.31 | -1.7% | 49.8% | CA$134.5b | CA$76.13 | PE174.7x | E67.5% | 3.0% | Diversified Financials | ||
PME | AU$285.81 | 0.8% | 191.0% | AU$29.9b | AU$254.50 | PE303.9x | E23.6% | 0.2% | Healthcare | ||
SMCI | US$56.07 | 17.0% | -34.8% | US$32.8b | US$47.88 | PE27.2x | E27.6% | n/a | Tech | ||
6669 | NT$2,080.00 | 1.7% | -4.1% | NT$386.5b | NT$3,002.06 | PE20.1x | E24.0% | 2.0% | Tech | ||
SYM | US$24.47 | -9.6% | -39.4% | US$15.2b | US$34.32 | PS1.4x | E84.6% | n/a | Capital Goods |